SOTIO Biotech Leadership Surge: Your ADC Pipeline Trigger

🚀 Battle Card: SOTIO Biotech

• Amy Jensen-Smith, Chief Scientific Officer · 🔗 [LinkedIn](https://www.linkedin.com/company/sotio-biotech/)

• Ulrich Moebius, Chief Development Officer · 🔗 [LinkedIn](https://www.linkedin.com/company/sotio-biotech/)

• Appointing veteran scientists to lead discovery and translational research cracks open the ADC and immunotherapy pipeline for better tumor targeting. This SOTIO Biotech sales trigger exposes rapid R&D scaling needs. → Source

• Need for integrated discovery platforms to accelerate ADC candidate selection

• Translational bottlenecks slowing IND-enabling workflows

• Primary: Integrated ADC discovery platform → speed candidate optimization by 30%

• Expansion: Translational informatics suite → streamline IND readiness and data handoff

• HQ: Prague, Czech Republic; Basel, Switzerland; Boston, MA

• Employees: ≈ 150

• Rev: ≈ $20 M

• Website: [https://www.sotio.com/](https://www.sotio.com/)

🤼 Competitive Intel

• Lonza — CDMO / CMC services
• Unique edge: End-to-end biologics development
• Evaluated by VP R&D for global clinical supply capacity

• Catalent — CDMO / Drug delivery
• Unique edge: Custom ADC conjugation technology
• Evaluated by Dir. Clinical Ops for scalable manufacturing

• WuXi AppTec — CDMO / R&D outsourcing
• Unique edge: Low-cost discovery and screening services
• Evaluated by VP Discovery for tight budget fit

• Syngene — CDMO / Preclinical services
• Unique edge: Integrated toxicology and GMP production
• Evaluated by Dir. Preclinical for safety profiling

✅ Do-Now Checklist

Next Step

🧠 Copy My Prompt for Personalized Cold Outreach

────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY   = ❑≈TBD❑
OFFER_BRIEF   = ❑Integrated ADC discovery platform❑
PROOF_METRIC  = ❑30% faster candidate selection❑
CTA_STYLE     = ❑quick_call | case_study❑
TONE          = ❑friendly | punchy❑

────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME        = Amy
COMPANY     = SOTIO Biotech
DEPT        = R&D
SIZE        = ≈20
BOTTLENECK  = lack of integrated ADC discovery platform
EVENT       = Strengthens leadership team
DETAIL      = your new CSO & CDO appointments
PAIN        = translational bottlenecks slowing IND readiness
SRC         = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20251002566770&div=41152219
SIM_CO      = ≈Morphosys
WIN_METRIC  = ≈30% faster selection
NEXT_SIZE   = ≈50
EMP_EST     = ≈150
REV_EST     = ≈$20M

────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.

Validate any ≈ guesses via SRC.

EMAIL  (keep breaks):
Subject: ≈20-person R&D

Amy—noticed your R&D team is ≈20.

That’s when lack of integrated ADC discovery platform slows growth.

We helped ≈Morphosys fix this with Integrated ADC discovery platform.

Result: ≈30% faster selection.  
Quick call?

PS—next bottleneck hits ≈50.

DM ≤45 words, TONE:
Saw your post about your new CSO & CDO appointments — translational bottlenecks slowing IND readiness.  
Integrated ADC discovery platform. 30% faster candidate selection.  
Quick chat?